19/99
Effectively limit expenditure on medicines
Introduced
22 November 2017
Last action
—
Status
Erledigt durch Ablauf der Wahlperiode
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
Presentation of a bill to reduce drug prices and promote therapeutic innovations: retroactive application of discount regulations from the first year of marketing, benefit-based design of the reimbursement price, consideration of research and development costs in price negotiations, reintroduction of the benefit assessment of existing products; Proof of additional benefit as part of the drug approval
Machine translation from German. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
19/99
Drucksache · DE · 22 November 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/ausgaben-bei-arzneimitteln-wirksam-begrenzen/230297
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/230297